T1	Participants 96 117	persons with HIV/AIDS
T2	Participants 250 364	icity in a sample of persons with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS)
T3	Participants 499 660	11 clinically stable, HIV-infected adults had been treated with highly active, antiretroviral therapy and had HIV plasma RNA levels of less than 10 000 copies/mL
